Therefore, we concluded that inhibition of Notch1 signaling pathway even with cisplatin treatment in osteosarcoma cells might directly or indirectly decrease the expression and/or activity of Caspase family proteins, generally leading to reduced sensitivity to cisplatin at last. The gene discussed is NOTCH1; the disease is osteosarcoma.